444

GENOMICS BIOSCI & TECH CO LTD

No trades
See on Supercharts
Market capitalization
‪1.34 B‬TWD
−2.35TWD
‪−168.07 M‬TWD
‪396.14 M‬TWD
Beta (1Y)
0.21

About GENOMICS BIOSCI & TECH CO LTD

CEO
Meng Hsien Chou
Headquarters
New Taipei
Founded
2001
ISIN
TW0004195003
FIGI
BBG005N22ZK6
Genomics BioSci & Tech. Co., Ltd. engages in the manufacture, research and development of biotechnological products and services. It offers DNA sequencing, library construction services, oligonucleotide synthesis, functional genomics cooperation, DNA mutation detection, biochemical, peptide synthesis, gene synthesis, and antibody preparation. The company was founded by Chou Te Yuan on October 16, 2001 and is headquartered in New Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4195 is 18.60 TWD — it has decreased by 0.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GENOMICS BIOSCI & TECH CO LTD stocks are traded under the ticker 4195.
GENOMICS BIOSCI & TECH CO LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
4195 stock is 1.90% volatile and has beta coefficient of 0.21. Check out the list of the most volatile stocks — is GENOMICS BIOSCI & TECH CO LTD there?
Yes, you can track GENOMICS BIOSCI & TECH CO LTD financials in yearly and quarterly reports right on TradingView.
4195 stock has risen by 5.08% compared to the previous week, the month change is a 3.13% fall, over the last year GENOMICS BIOSCI & TECH CO LTD has showed a 6.54% decrease.
4195 net income for the last quarter is ‪−89.77 M‬ TWD, while the quarter before that showed ‪−78.30 M‬ TWD of net income which accounts for −14.65% change. Track more GENOMICS BIOSCI & TECH CO LTD financial stats to get the full picture.
Today GENOMICS BIOSCI & TECH CO LTD has the market capitalization of ‪1.34 B‬, it has increased by 0.55% over the last week.
Yes, 4195 dividends are paid annually. The last dividend per share was 0.10 TWD. As of today, Dividend Yield (TTM)% is 0.53%. Tracking GENOMICS BIOSCI & TECH CO LTD dividends might help you take more informed decisions.
Like other stocks, 4195 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMICS BIOSCI & TECH CO LTD stock right from TradingView charts — choose your broker and connect to your account.
4195 reached its all-time high on Jul 4, 2014 with the price of 48.55 TWD, and its all-time low was 9.45 TWD and was reached on Nov 1, 2017.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMICS BIOSCI & TECH CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMICS BIOSCI & TECH CO LTD stock shows the sell signal. See more of GENOMICS BIOSCI & TECH CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMICS BIOSCI & TECH CO LTD EBITDA is ‪−41.92 M‬ TWD, and current EBITDA margin is −10.58%. See more stats in GENOMICS BIOSCI & TECH CO LTD financial statements.